Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.640
+0.060 (2.33%)
Jul 16, 2026, 10:26 AM EDT - Market open
Silexion Therapeutics Employees
As of December 31, 2025, Silexion Therapeutics had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
14
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$922,143
Market Cap
1.11M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 0 | - | 13 | 1 |
| Dec 31, 2024 | 14 | - | - | 11 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Biodexa Pharmaceuticals | 11 |
| CDT Equity | 4 |
SLXN News
- 23 days ago - Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer - GlobeNewsWire
- 4 weeks ago - Silexion Therapeutics to Attend BIO International Convention 2026 - GlobeNewsWire
- 4 weeks ago - Silexion Therapeutics files to sell 859,609 ordinary shares for holders - TheFly
- 6 weeks ago - Silexion Therapeutics Corp trading halted, news pending - TheFly
- 7 weeks ago - Silexion Therapeutics announces 1-for-10 reverse share split - TheFly
- 7 weeks ago - Silexion Therapeutics Announces 1-for-10 Reverse Share Split - GlobeNewsWire
- 7 weeks ago - 3 Penny Stocks to Watch Now, 5/21/26 - TipRanks
- 2 months ago - Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire